We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
(-83%)
Cap. Flow
-$6.76B
Cap. Flow
% of AUM
-444.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
First Horizon
FHN
|
+$107M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$54.9M |
| 4 |
VMW
VMware, Inc
VMW
|
+$34.9M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
Rogers Corp
ROG
|
+$432M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.54% |
| 2 | Healthcare | 36.97% |
| 3 | Financials | 14.43% |
| 4 | Communication Services | 3.06% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPT
251
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-8,727
| Closed | -$1.68M |
|
252
PUT
Royal Caribbean
RCL
$85.7B
| – | – |
-54,200
| Closed | -$1.88M |
|
253
Arcus Biosciences
RCUS
$3.61B
| – | – |
-38,725
| Closed | -$1.01M |
|
254
PUT
Radian Group
RDN
$4.82B
| – | – |
-31,500
| Closed | -$56K |
|
255
Roadzen Inc Warrants
RDZNW
$10.1M
| – | – |
-71,020
| Closed | -$8K |
|
|
256
Roadzen
RDZN
$105M
| – | – |
-233,953
| Closed | -$2.35M |
|
257
Rexford Industrial Realty
REXR
$8.14B
| – | – |
-456,618
| Closed | -$23.7M |
|
258
PUT
Transocean
RIG
$5.71B
| – | – |
-1,967,700
| Closed | -$2.07M |
|
259
Rigel Pharmaceuticals
RIGL
$733M
| – | – |
-28,614
| Closed | -$338K |
|
|
RDNW
260
RideNow Group
RDNW
$264M
| – | – |
-150,000
| Closed | -$2.54M |
|
261
ReNew
RNW
$2.27B
| – | – |
-311,739
| Closed | -$1.88M |
|
|
262
Rogers Corp
ROG
$2.39B
| – | – |
-1,786,302
| Closed | -$432M |
|
263
PUT
Range Resources
RRC
$9.01B
| – | – |
-35,400
| Closed | -$10K |
|
264
Republic Services
RSG
$64.5B
| – | – |
-67,648
| Closed | -$9.2M |
|
|
RWT
265
Redwood Trust
RWT
$573M
| – | – |
-516,638
| Closed | -$2.97M |
|
266
Ryanair
RYAAY
$31.4B
| – | – |
-673,443
| Closed | -$15.7M |
|
267
Rhythm Pharmaceuticals
RYTM
$7.72B
| – | – |
-72,375
| Closed | -$1.77M |
|
268
SentinelOne
S
$7.12B
| – | – |
-110,000
| Closed | -$2.81M |
|
|
SAFE
269
PUT
Safehold
SAFE
$1.13B
| – | – |
-17,606
| Closed | -$623K |
|
270
SBA Communications
SBAC
$19.4B
| – | – |
-37,213
| Closed | -$10.6M |
|
271
Sabra Healthcare REIT
SBRA
$5.34B
| – | – |
-251,789
| Closed | -$3.3M |
|
272
SCYNEXIS
SCYX
$51.6M
| – | – |
-66,959
| Closed | -$1.29M |
|
273
Schrodinger
SDGR
$1.33B
| – | – |
-79,547
| Closed | -$1.99M |
|
274
PUT
Shake Shack
SHAK
$2.84B
| – | – |
-50,000
| Closed | -$250K |
|
275
Shell
SHEL
$248B
| – | – |
-45,303
| Closed | -$2.25M |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
- UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
- UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.